LIU Gui-mei,XIA Guang-rong,JIN Guo-hua.Late-course hyperfractionation accelerated radiotherapy for locally advanced non-small cell lung cancer[J].Chinese Journal of Radiological Medicine and Protection,2006,26(4):383-385
Late-course hyperfractionation accelerated radiotherapy for locally advanced non-small cell lung cancer
Received:April 04, 2006  
DOI:
KeyWords:Non-small cell lung cancer  Late-course hyperfractionation accelerated radiotherapy  Prognosis
FundProject:
Author NameAffiliation
LIU Gui-mei Department of Radiation Oncology, Beijing Thoracic Tumor Hospital, Beijing 101149, China 
XIA Guang-rong Department of Radiation Oncology, Beijing Thoracic Tumor Hospital, Beijing 101149, China 
JIN Guo-hua Department of Radiation Oncology, Beijing Thoracic Tumor Hospital, Beijing 101149, China 
Hits: 2576
Download times: 1876
Abstract::
      Objective To study the toxicities and efficacy of late course hyperfractionation accelerated radiotherapy(LCHART) in unresectable locally advanced non-small cell lung cancer (NSCLC). Methods Fifty-six unresectable stage Ⅲa-Ⅲb NSCLC patients eligible for this study were treated with conventional fractionation radiotherapy (2 Gy/f,1 f/d, 40 Gy in total) with AP-PA large fields encompassing the primary tumor, positive lymph nodes and elective lymph node region,and followed by LCHART(1.5 Gy/f,2 f/d, 26-30 Gy in total) with cone-down fields covering primary tumor.Efficacy was evaluated by enhanced CT scanning. Results The response rate was 67.9% 1 month after completion of radiotherapy.The median survival time (MST) was 12 months.The 1-,2-,3-,and 4-year overall survival rate were 53.6%,19.6%,5.4% and 3.6%,respectively.Grade Ⅱ radiation esophagitis was observed in 20 patients,grade Ⅲ radiation esophagitis in 2 patients; grade Ⅱ radiation pneumonitis in 2 patients; grade Ⅱ late lung fibrosis in 5 patients,and grade Ⅲ in 1 patient.Conclusion The doses used in late-course hyperfractionation accelerated radiotherapy for locally advanced non-small cell lung cancer can be increased noticeably.Late-course hyperfractionation accelerated radiotherapy had excellent short-term effect;its toxicity was acceptable.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9063618  On-line:0

v
Scan QR Code
&et=5E4F9853967EC3501C9CC71F6BF06494E2DEE92B33B469CA875603D4ACD446867790C08F4738B411E267C464D51C005A829999B3A2E61C4FC778190C5C0163ED0031E55F54C973CB632F5CCB09BE851F7E87F7F224E8A26CA6F024B8FCB370004FAFAA0F542B098E&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=37904DC365DD7266&aid=5B25BF7DF39071A8&vid=&iid=E158A972A605785F&sid=663FF78B2ADE7A2D&eid=44FDB9366EDDFA2B&fileno=20060424&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="37904DC365DD7266"; var my_aid="5B25BF7DF39071A8";